The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.
about
α-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced NeuropathologyLong-term neuropathological and behavioral impairments after exposure to nerve agentsAntiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) ReceptorsMidazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisalA rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonistsThe basolateral amygdala γ-aminobutyric acidergic system in health and disease.Neurosteroids for the potential protection of humans against organophosphate toxicity.The Glutamate-Glutamine Cycle in Epilepsy.A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats.Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models.Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.
P2860
Q26777019-A08F0DB2-30B5-47B9-BA2C-205CE8DB59BFQ30354960-60187D63-F483-4C4C-B199-B6F312026D1EQ35600228-5DA89A63-6B50-4158-A2FA-BEB6A487BFD8Q35688988-FABAB1F6-E84D-42D1-B7FA-2477EBFA89B4Q35985022-B6130887-3446-4D00-B0E6-C1A1744A4FB2Q36813950-152A6C0F-20D5-4128-8148-22003D7E1145Q38906587-6395B471-099E-416A-88BA-B6E4D1FA0100Q39019326-7FC89619-3F4A-4E5D-912B-7CFAC49B850EQ41295349-32EC5FC3-5DB0-481F-8D1B-98309BE970B5Q47920504-9F5A30A9-8A73-4E3C-9EC3-8447CA5A260AQ48166589-65A7E64A-2292-4559-98D1-595B1513CA4AQ48448168-67F8A429-EF9C-466D-AF2D-24E62A3E8CA1Q48663292-30A47D5A-DC50-4CA9-A813-41F4B74AA705Q49310896-C7DF33D2-8697-4E0E-B926-4808D41F26B5Q51749309-485EE804-B7BF-4ED1-A57A-D58B4E1E00CCQ54967844-098BA8E4-7A06-49E0-8995-EC19B67D322F
P2860
The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The limitations of diazepam as ...... rats: comparison with UBP302.
@ast
The limitations of diazepam as ...... rats: comparison with UBP302.
@en
type
label
The limitations of diazepam as ...... rats: comparison with UBP302.
@ast
The limitations of diazepam as ...... rats: comparison with UBP302.
@en
prefLabel
The limitations of diazepam as ...... rats: comparison with UBP302.
@ast
The limitations of diazepam as ...... rats: comparison with UBP302.
@en
P2093
P2860
P356
P1476
The limitations of diazepam as ...... n rats: comparison with UBP302
@en
P2093
Franco Rossetti
James P Apland
Maria F M Braga
Taiza H Figueiredo
Vassiliki Aroniadou-Anderjaska
P2860
P304
P356
10.1124/JPET.114.217299
P407
P577
2014-08-25T00:00:00Z